
Wall Street Opens Soft as GLPâ1 Makers Rally and a Generic Challenger Collapses
U.S. markets opened slightly lower as gains in GLPâ1 weightâloss drug makers were offset by weakness in memory stocks. Novo Nordisk and Eli Lilly rose on continued enthusiasm for semaglutideâclass therapies, while Hims & Hers plunged after facing litigation over a generic version. Micron fell amid renewed pressure on cyclical tech names.


















